NewsRx

Search our medical news database

Financing

Surface Logix Inc. Raises $20 Million in Second Tranche of Series D Financing

Published in Medical Verdicts and Law Weekly, April 19th, 2007

Surface Logix Inc. announced that it has closed on $20 million in a second tranche of the Company's Series D financing. The first close for this round took place in October 2005 and brought in proceeds of $32 million. The additional funds bring the total proceeds for the round to $52 million. Participants in the round included current Surface Logix investors, Venrock Associates, ARCH Venture Partners, CW Group, HBM BioVentures, Unilever Technology Ventures and others.

"We are grateful for the strong support from our investors, and based on the significant progress we made over the last 18 months, we were able to raise twice the amount originally anticipated for this...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook